IL

Indulekha Lalitha Chandrasekharan Pillai

Active Director Designated Partner DIN 11167953
DIN 11167953 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Indulekha Lalitha Chandrasekharan Pillai

Data last updated:

Indulekha Lalitha Chandrasekharan Pillai is a Designated Partner at Krishnas Bioinnovations Llp (since 2025).

DIN 11167953
Primary Designation Designated Partner
First Appointment 24 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Jun 20252025Active

Board colleagues of Indulekha Lalitha Chandrasekharan Pillai

NameDINCompanyDesignation
Devika Narendran Salini11167954Krishnas Bioinnovations LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Krishnas Bioinnovations Llp
Premium access

Shareholding and investment profile for Indulekha Lalitha Chandrasekharan Pillai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indulekha Lalitha Chandrasekharan Pillai

Indulekha Lalitha Chandrasekharan Pillai currently holds 1 directorship: Krishnas Bioinnovations Llp (Designated Partner, since 24 Jun 2025).

Indulekha Lalitha Chandrasekharan Pillai was first appointed on 24 Jun 2025 as Designated Partner at Krishnas Bioinnovations Llp.

The current boards of Indulekha Lalitha Chandrasekharan Pillai's companies include Devika Narendran Salini (Krishnas Bioinnovations Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available